<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38874693</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2509-2723</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults.</ArticleTitle><Pagination><StartPage>6563</StartPage><EndPage>6581</EndPage><MedlinePgn>6563-6581</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-024-01227-8</ELocationID><Abstract><AbstractText>Long COVID, also known as PASC (post-acute sequelae of SARS-CoV-2), is a complex infection-associated chronic condition affecting tens of millions of people worldwide. Many aspects of this condition are incompletely understood. Among them is how this condition may manifest itself in older adults and how it might impact the older population. Here, we briefly review the current understanding of PASC in the adult population and examine what is known on its features with aging. Finally, we outline the major gaps and areas for research most germane to older adults.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to American Aging Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Russell</LastName><ForeName>Samantha J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Geriatrics, and Palliative Medicine, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona Center of Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Banner University Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Parker</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Geriatrics, and Palliative Medicine, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona Center of Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Banner University Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehoczki</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Doctoral College, Health Sciences Program, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Haematology and Stem Cell Transplantation, National Institute for Haematology and Infectious Diseases, South Pest Central Hospital, 1097, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Geriatrics, and Palliative Medicine, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona Center of Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Banner University Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Partha</LastName><ForeName>Indu S</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Geriatrics, and Palliative Medicine, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Banner University Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Serena J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Geriatrics, and Palliative Medicine, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona Center of Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Banner University Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Linda R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Geriatrics, and Palliative Medicine, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona Center of Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Nursing, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fain</LastName><ForeName>Mindy J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Geriatrics, and Palliative Medicine, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA. mfain@aging.arizona.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona Center of Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA. mfain@aging.arizona.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Banner University Medicine-Tucson, Tucson, AZ, USA. mfain@aging.arizona.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Nursing, University of Arizona, Tucson, AZ, USA. mfain@aging.arizona.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Nikolich</LastName><ForeName>Janko &#x17d;</ForeName><Initials>J&#x17d;</Initials><Identifier Source="ORCID">0000-0001-5830-5323</Identifier><AffiliationInfo><Affiliation>Arizona Center of Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA. nikolich@arizona.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA. nikolich@arizona.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Aegis Consortium for Pandemic-Free Future, University of Arizona Health Sciences, Tucson, AZ, USA. nikolich@arizona.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R25AG076387</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37AG020719</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 AG076387</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical presentation</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Molecular mechanisms</Keyword><Keyword MajorTopicYN="N">Older adults</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38874693</ArticleId><ArticleId IdType="pmc">PMC11493926</ArticleId><ArticleId IdType="doi">10.1007/s11357-024-01227-8</ArticleId><ArticleId IdType="pii">10.1007/s11357-024-01227-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. Female gender is associated with Long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e619-611.e616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, et al. Post-COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years &#x2014; United States, March 2020&#x2013;November 2021. Morb Mortal Wkly Rep. 2022;71(21):713&#x2013;7.</Citation></Reference><Reference><Citation>Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after COVID-19 and Long COVID in a national Swedish cohort. BMC Public Health. 2021;21(1):1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164957</ArticleId><ArticleId IdType="pubmed">34059034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett PG, Rockwood K, Carver D, Stolee P, Cosway S. Illness presentation in elderly patients. Arch Intern Med. 1995;155(10):1060&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">7748049</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung YJ, Yoon JL, Kim HS, Lee A-Y, Kim MY, Cho JJ. Atypical clinical presentation of geriatric syndrome in elderly patients with pneumonia or coronary artery disease. Ann Geriatr Med Res. 2017;21(4):158&#x2013;63.</Citation></Reference><Reference><Citation>Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis. 2004;4(2):112&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">14871636</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt C, Olcott F, Williams G, Chan T. Failing the frail: the need to broaden the COVID-19 case definition for geriatric patients. Clin Med (Lond). 2021;21(6):e604&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806293</ArticleId><ArticleId IdType="pubmed">34642166</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics NCfH. Percent of U.S. adults 55 and over with chronic conditions. 2015. https://www.cdc.gov/nchs/health_policy/adult_chronic_conditions.htm. Accessed May 17, 2024.</Citation></Reference><Reference><Citation>Prevention CfDCa. Older adult falls data. 2024. https://www.cdc.gov/falls/data-research/?CDC_AAref_Val=https://www.cdc.gov/falls/data/index.html. Accessed May 17, 2024.</Citation></Reference><Reference><Citation>Manly JJ, Jones RN, Langa KM, et al. Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project. JAMA Neurol. 2022;79(12):1242&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9593315</ArticleId><ArticleId IdType="pubmed">36279130</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in Long COVID-19. N Engl J Med. 2022;387(19):1813&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes-Ibarra M, Oliveira CLP, Orsso CE, Landi F, Marzetti E, Prado CM. The impact of Long COVID-19 on muscle health. Clin Geriatr Med. 2022;38(3):545&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8934728</ArticleId><ArticleId IdType="pubmed">35868672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman GJ, Ha J, Alexander NB, Langa KM, Tinetti M, Min LC. Underreporting of fall injuries of older adults: implications for wellness visit fall risk screening. J Am Geriatr Soc. 2018;66(6):1195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105546</ArticleId><ArticleId IdType="pubmed">29665016</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Hamdh B, Nazzal Z. A prospective cohort study assessing the relationship between Long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination. Sci Rep. 2023;13(1):4896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10039348</ArticleId><ArticleId IdType="pubmed">36966161</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of Long COVID. Nat Med. 2021;27(4):626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12(1):6571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Rocca CCA, Serafim AP, et al. Cognitive impairment in Long-COVID and its association with persistent dysregulation in inflammatory markers. Front Immunol. 2023;14:1174020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10242059</ArticleId><ArticleId IdType="pubmed">37287969</ArticleId></ArticleIdList></Reference><Reference><Citation>Messin L, Puyraveau M, Benabdallah Y, et al. COVEVOL: natural evolution at 6 months of COVID-19. Viruses. 2021;13(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619893</ArticleId><ArticleId IdType="pubmed">34834958</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Giuriato M. Demographic and clinical factors associated with Long COVID. Health Aff (Millwood). 2023;42(3):433&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">36877912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, Ramakrishnan RK, et al. Long term predictors of breathlessness, exercise intolerance, chronic fatigue and well-being in hospitalized patients with COVID-19: a cohort study with 4 months median follow-up. J Infect Public Health. 2022;15(1):21&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600938</ArticleId><ArticleId IdType="pubmed">34861604</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberian P, Pazooki B, Hasani-Sharamin P, et al. Persistent/late-onset complications of COVID-19 in general population: a cross-sectional study in Tehran. Iran Int J Community Based Nurs Midwifery. 2022;10(3):234&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9287568</ArticleId><ArticleId IdType="pubmed">35855388</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Wang YR, Wang QH, et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener. 2021;16(1):48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, Carf&#xec; A, Martis I, et al. Prevalence and predictors of persistence of COVID-19 symptoms in older adults: a single-center study. J Am Med Dir Assoc. 2021;22(9):1840&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou GN, Baraff A, Fox A, et al. Rates and factors associated with documentation of diagnostic codes for Long COVID in the National Veterans Affairs Health Care System. JAMA Netw Open. 2022;5(7):e2224359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9338411</ArticleId><ArticleId IdType="pubmed">35904783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi&#x144;ko A, Turo&#x144;-Skrzypi&#x144;ska A, Ry&#x142; A, Tomska N, Bereda Z, Rotter I. Searching for factors influencing the severity of the symptoms of Long COVID. Int J Environ Res Public Health. 2022;19(13).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9265986</ArticleId><ArticleId IdType="pubmed">35805671</ArticleId></ArticleIdList></Reference><Reference><Citation>Daitch V, Yelin D, Awwad M, et al. Characteristics of Long-COVID among older adults: a cross-sectional study. Int J Infect Dis. 2022;125:287&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">36191820</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydin S, Unver E, Karavas E, Yalcin S, Kantarci M. Computed tomography at every step: long coronavirus disease. Respir Investig. 2021;59(5):622&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238689</ArticleId><ArticleId IdType="pubmed">34210624</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras PJ, Romero-Albino Z, Cuba-Fuentes MS. Description of frequent and persistent symptoms of COVID-19 among older adults who attend senior centers. Medwave. 2022;22(1):e8689.</Citation><ArticleIdList><ArticleId IdType="pubmed">35100246</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher H, Chaftari AM, Subbiah IM, et al. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife. 2023;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9977271</ArticleId><ArticleId IdType="pubmed">36748905</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4(1):e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M, Babicki M, Mastalerz-Migas A, Kapusta J. Persisting smell and taste disorders in patients who recovered from SARS-CoV-2 virus infection-data from the Polish PoLoCOV-CVD Study. Viruses. 2022;14(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9416276</ArticleId><ArticleId IdType="pubmed">36016385</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics NCfH. U.S. Census Bureau, Household Pulse Survey, 2022&#x2013;2024.&#xa0;Long COVID 2024. https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm.</Citation></Reference><Reference><Citation>Nguyen KH, Bao Y, Mortazavi J, Allen JD, Chocano-Bedoya PO, Corlin L. Prevalence and factors associated with Long COVID symptoms among U.S. adults, 2022. Vaccines (Basel). 2024;12(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10820629</ArticleId><ArticleId IdType="pubmed">38250912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Chung VC, Chan DC, et al. Determinants of post-COVID-19 symptoms among adults aged 55 or above with chronic conditions in primary care: data from a prospective cohort in Hong Kong. Front Public Health. 2023;11:1138147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10196359</ArticleId><ArticleId IdType="pubmed">37213637</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Baricich A, Patrucco F, et al. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep. 2021;11(1):22666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8608998</ArticleId><ArticleId IdType="pubmed">34811387</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi HY, Alrashed AM, Jawhari AM, Abdel-Moneim AS. Neuropsychiatric symptoms in post-COVID-19 long haulers. Acta Neuropsychiatr. 2022;34(6):318&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">35543105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauria A, Carf&#xec; A, Benvenuto F, et al. Neuropsychological measures of Long COVID-19 fog in older subjects. Clin Geriatr Med. 2022;38(3):593&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9080120</ArticleId><ArticleId IdType="pubmed">35868675</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Rodr&#xed;guez BM, Guti&#xe9;rrez-Fern&#xe1;ndez J, Ramos-Urbina EM, et al. On the single and multiple associations of COVID-19 post-acute sequelae: 6-month prospective cohort study. Sci Rep. 2022;12(1):3402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8888754</ArticleId><ArticleId IdType="pubmed">35233062</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento T, do Valle Costa L, Ruiz AD, et al. Vaccination status and Long COVID symptoms in patients discharged from hospital. Sci Rep. 2023;13(1):2481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9922040</ArticleId><ArticleId IdType="pubmed">36774419</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S, Zanjari N, Yassin M, Yassin Z, Tavahomi M. Association between Long COVID, functional activity, and health-related quality of life in older adults. BMC Geriatr. 2023;23(1):40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9868494</ArticleId><ArticleId IdType="pubmed">36690948</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J, Rodgers YVM. Long COVID prevalence, disability, and accommodations: analysis across demographic groups. J Occup Rehabil. 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11179968</ArticleId><ArticleId IdType="pubmed">38388910</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ramasamy A, Verduzco-Gutierrez M, Brode WM, Melamed E. Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants. Virol J. 2023;20(1):124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10276420</ArticleId><ArticleId IdType="pubmed">37328773</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger Z, Altiery DEJV, Assoumou SA, Greenhalgh T. Long COVID and health inequities: the role of primary care. Milbank Q. 2021;99(2):519&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8241274</ArticleId><ArticleId IdType="pubmed">33783907</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens CD, Pertuz GM, Sanchez JC, et al. The COVID-19 pandemic in a Hispanic population: a primary care perspective. J Am Board Fam Med. 2022;35(4):686&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">35896459</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw E, Yashadhana A, Hitch D. Long COVID: sustained and multiplied disadvantage. Med J Aust. 2022;216(5):222&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115005</ArticleId><ArticleId IdType="pubmed">35249215</ArticleId></ArticleIdList></Reference><Reference><Citation>Karpman M, Zuckerman S, Morriss S. Health care access and affordability among US adults aged 18 to 64 years with self-reported post-COVID-19 condition. JAMA Netw Open. 2023;6(4):e237455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10087049</ArticleId><ArticleId IdType="pubmed">37036705</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of Long COVID-19. J Natl Med Assoc. 2023;115(2):233&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923441</ArticleId><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Bulled N. Long COVID: a syndemics approach to understanding and response. Appl Res Qual Life. 2024;19(2):811&#x2013;34.</Citation></Reference><Reference><Citation>Guo Y, Guo Y, Zhang Y, et al. Factors affecting prolonged SARS-CoV-2 infection and development and validation of predictive nomograms. J Med Virol. 2023;95(2):e28550.</Citation><ArticleIdList><ArticleId IdType="pubmed">36734068</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881-895.e820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammel IS, Tosi DM, Tang F, Pott H, Ruiz JG. Frailty as a risk factor for post-acute sequelae of COVID-19 among US veterans during the delta and omicron waves. J Am Geriatr Soc. 2023;71(12):3826&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">37725480</ArticleId></ArticleIdList></Reference><Reference><Citation>LaVergne SM, Stromberg S, Baxter BA, et al. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect Dis. 2021;21(1):677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276222</ArticleId><ArticleId IdType="pubmed">34256735</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro L, Zaccone V, Falsetti L, et al. Role of endothelium in cardiovascular sequelae of Long COVID. Biomedicines. 2023;11(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10452509</ArticleId><ArticleId IdType="pubmed">37626735</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of Long COVID. Nat Rev Immunol. 2023;23(10):618&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R, Shunmugam L, Naidoo K, et al. Long COVID: a review and proposed visualization of the complexity of Long COVID. Front Immunol. 2023;14:1117464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, et al. Pathophysiology and mechanism of Long COVID: a comprehensive review. Ann Med. 2022;54(1):1473&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB, Force RMPT. Viral persistence, reactivation, and mechanisms of Long COVID. Elife. 2023;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of Long COVID. Neuron. 2022;110(21):3484&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of Long COVID. Lancet Infect Dis. 2023;23(4):393&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB, Force RMPT. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Weiman S, Holtzman M, Blish C, Pretorius R, Deeks SG. Long COVID and post-acute sequelae of SARS-CoV-2 pathogenesis and treatment: a Keystone Symposia report. Ann N Y Acad Sci. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38593220</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R, Shunmugam L, Naidoo K, et al. Biological mechanisms underpinning the development of Long COVID. iScience. 2023;26(6):106935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10193768</ArticleId><ArticleId IdType="pubmed">37265584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495-506 e498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper JE, Padera RF, Dolhnikoff M, et al. A postmortem portrait of the coronavirus disease 2019 (COVID-19) pandemic: a large multi-institutional autopsy survey study. Arch Pathol Lab Med. 2021;145(5):529&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">33449998</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612(7941):758&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Swank ZN, Goldberg SA, et al. Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection. medRxiv. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">38604216</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76(3):e487&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrich DT. Keystone symposium on Long COVID, August 27&#x2013;31, 2023.</Citation></Reference><Reference><Citation>Lee S, Yu Y, Trimpert J, et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599(7884):283&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Perlman S. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity. J Clin Invest. 2020;130(12):6204&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685716</ArticleId><ArticleId IdType="pubmed">33085654</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji S, Minami S, Hashimoto R, et al. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response. Nat Aging. 2022;2(2):115&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154207</ArticleId><ArticleId IdType="pubmed">37117754</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. COVID-19 and cellular senescence. Nat Rev Immunol. 2023;23(4):251&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9533263</ArticleId><ArticleId IdType="pubmed">36198912</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimann M, Lee S, Schmitt CA. Cellular senescence: neither irreversible nor reversible. J Exp Med. 2024;221(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10883852</ArticleId><ArticleId IdType="pubmed">38385946</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblanc P, Vorberg IM. Viruses in neurodegenerative diseases: more than just suspects in crimes. PLoS Pathog. 2022;18(8):e1010670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352104</ArticleId><ArticleId IdType="pubmed">35925897</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz L, Hornung F, H&#xe4;der A, et al. Influenza virus-induced paracrine cellular senescence of the lung contributes to enhanced viral load. Aging Dis. 2023;14(4):1331&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389813</ArticleId><ArticleId IdType="pubmed">37163429</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Tian M, Wang G, et al. Senotherapeutics: an emerging approach to the treatment of viral infectious diseases in the elderly. Front Cell Infect Microbiol. 2023;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10094634</ArticleId><ArticleId IdType="pubmed">37065192</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in Long COVID. Viruses. 2023;15(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, et al. Chronic viral coinfections differentially affect the likelihood of developing Long COVID. J Clin Invest. 2023;133(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(1):10&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29242543</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolou E, Rizwan M, Moustardas P, et al. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome. Front Immunol. 2022;13:949787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9630598</ArticleId><ArticleId IdType="pubmed">36341457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffieux H, Hanson AL, Lodge S, et al. A patient-centric modeling framework captures recovery from SARS-CoV-2 infection. Nat Immunol. 2023;24(2):349&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9892000</ArticleId><ArticleId IdType="pubmed">36717723</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Nguyen DC, et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020;21(12):1506&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Bonham KS, Anam FA, et al. Chronic inflammation, neutrophil activity, and autoreactivity splits Long COVID. Nat Commun. 2023;14(1):4201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadley EC, Kuchel GA, Newman AB, et al. Corrigendum to: Report: NIA workshop on measures of physiologic resiliencies in human aging. J Gerontol A Biol Sci Med Sci. 2018;73(7):995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6001895</ArticleId><ArticleId IdType="pubmed">29788088</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng SX, Margolick JB. Aging, sex, inflammation, frailty, and CMV and HIV infections. Cell Immunol. 2020;348:104024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7002257</ArticleId><ArticleId IdType="pubmed">31843200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyongyosi M, Alcaide P, Asselbergs FW, et al. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc Res. 2023;119(2):336&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology &amp; Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res. 2021;117(14):2705&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500019</ArticleId><ArticleId IdType="pubmed">34528075</ArticleId></ArticleIdList></Reference><Reference><Citation>Garay B, Phachu D, Manickaratnam S. Glomerular endotheliosis in COVID-19-associated acute kidney injury. Cureus. 2022;14(7):e27147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9393045</ArticleId><ArticleId IdType="pubmed">36017293</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon-Cama V, Montero-Gonzalez T, Acosta-Medina EF, et al. Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis. Arch Virol. 2023;168(3):96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9968404</ArticleId><ArticleId IdType="pubmed">36842152</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibila O, Perea L, Albacar N, et al. Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. Respir Res. 2022;23(1):37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860292</ArticleId><ArticleId IdType="pubmed">35189887</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffre J, Rodriguez L, Matthay ZA, et al. COVID-19-associated lung microvascular endotheliopathy: a &#x201c;From the Bench&#x201d; perspective. Am J Respir Crit Care Med. 2022;206(8):961&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9801996</ArticleId><ArticleId IdType="pubmed">35649173</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulli A, Gotelli E, Bica PF, et al. Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors. Microvasc Res. 2022;142:104361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942583</ArticleId><ArticleId IdType="pubmed">35339493</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens CD, Bonin Pinto C, Mukli P, et al. Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: protocol and methodology of a prospective longitudinal observational study. PLoS One. 2023;18(8):e0289508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10399897</ArticleId><ArticleId IdType="pubmed">37535668</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens CD, Pinto CB, Detwiler S, et al. Cerebral small vessel disease pathology in COVID-19 patients: a systematic review. Ageing Res Rev. 2023;88:101962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10202464</ArticleId><ArticleId IdType="pubmed">37224885</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnevale S, Beretta P, Morbini P. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea. J Med Virol. 2021;93(1):61&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300801</ArticleId><ArticleId IdType="pubmed">32492199</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Han K, Blair R, et al. SARS-CoV-2 infects endothelial cells in vivo and in vitro. Front Cell Infect Microbiol. 2021;11:701278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8292147</ArticleId><ArticleId IdType="pubmed">34307198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishijima Y, Hader SN, Hanson AJ, et al. Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2. Cardiovasc Res. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689948</ArticleId><ArticleId IdType="pubmed">34755839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner JUG, Bojkova D, Shumliakivska M, et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol. 2021;116(1):42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256413</ArticleId><ArticleId IdType="pubmed">34224022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, Lampe J, Muller-Fielitz H, et al. The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci. 2021;24(11):1522&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox SE, Li G, Akmatbekov A, et al. Unexpected features of cardiac pathology in COVID-19 infection. Circulation. 2020;142(11):1123&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32689809</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Brasen JH, Hoeper MM, David S. Direct evidence of SARS-CoV-2 in gut endothelium. Intensive Care Med. 2020;46(11):2081&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483488</ArticleId><ArticleId IdType="pubmed">32915253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesti A, Danics K, Glasz T, et al. Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies. Geroscience. 2022:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9759055</ArticleId><ArticleId IdType="pubmed">36527584</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini D, Kawakami R, Guagliumi G, et al. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation. 2021;143(10):1031&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">33480806</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV Study. Front Cardiovasc Med. 2021;8:745758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of Long COVID syndrome. J Thromb Haemost. 2021;19(10):2546&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehi E, Chilimuri S, Shin D, Patel M, Ali N, Niazi M. Microthrombi in skin biopsy of a patient with COVID-19. JAAD Case Rep. 2020;6(12):1327&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550272</ArticleId><ArticleId IdType="pubmed">33072831</ArticleId></ArticleIdList></Reference><Reference><Citation>Guagliumi G, Sonzogni A, Pescetelli I, Pellegrini D, Finn AV. Microthrombi and ST-segment-elevation myocardial infarction in COVID-19. Circulation. 2020;142(8):804&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439756</ArticleId><ArticleId IdType="pubmed">32677840</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Ruiz I. Microthrombi cause cardiac injury in COVID-19. Nat Rev Cardiol. 2021;18(5):306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859892</ArticleId><ArticleId IdType="pubmed">33542519</ArticleId></ArticleIdList></Reference><Reference><Citation>Bois MC, Boire NA, Layman AJ, et al. COVID-19-associated nonocclusive fibrin microthrombi in the heart. Circulation. 2021;143(3):230&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805556</ArticleId><ArticleId IdType="pubmed">33197204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Zhao B, Li T, Yang Z, Li S, Le W. Risk of ischemic stroke in patients with COVID-19 infection: a systematic review and meta-analysis. Brain Res Bull. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719366</ArticleId><ArticleId IdType="pubmed">34979237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sashindranath M, Nandurkar HH. Endothelial dysfunction in the brain: setting the stage for stroke and other cerebrovascular complications of COVID-19. Stroke. 2021;52(5):1895&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078121</ArticleId><ArticleId IdType="pubmed">33794655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluis WM, Linschoten M, Buijs JE, et al. Risk, clinical course, and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study. Stroke. 2021;52(12):3978&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8607920</ArticleId><ArticleId IdType="pubmed">34732073</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutch C, Thrombosis C, Kaptein FHJ, et al. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res. 2021;199:143&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832218</ArticleId><ArticleId IdType="pubmed">33535120</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L, Kaiser R, Stark K. Thromboinflammation in Long COVID-the elusive key to postinfection sequelae? J Thromb Haemost. 2023;21(8):2020&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>McMaster MW, Dey S, Fishkin T, Wang A, Frishman WH, Aronow WS. The impact of Long COVID-19 on the cardiovascular system. Cardiol Rev. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38285646</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42(2):505&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145538</ArticleId><ArticleId IdType="pubmed">32274617</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol. 2017;312(1):H1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5283909</ArticleId><ArticleId IdType="pubmed">27793855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Toth P, Tarantini S, et al. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol. 2021;17(10):639&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8202227</ArticleId><ArticleId IdType="pubmed">34127835</ArticleId></ArticleIdList></Reference><Reference><Citation>Adingupu DD, Soroush A, Hansen A, Twomey R, Dunn JF. Reduced cerebrovascular oxygenation in individuals with post-acute COVID-19 syndrome (PACS) (&#x201c;Long COVID&#x201d;). Adv Exp Med Biol. 2023;1438:211&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">37845463</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen C, Rowe PC, Visser FC. Orthostatic symptoms and reductions in cerebral blood flow in Long-Haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina (Kaunas). 2021;58(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani Z, Liu J, Su H. Vascular dysfunctions contribute to the long-term cognitive deficits following COVID-19. Biology (Basel). 2023;12(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10451811</ArticleId><ArticleId IdType="pubmed">37626992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetanov KA, Spindler LRB, Stamatakis EA, et al. Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: a prospective observational cohort study. Neuroimage Clin. 2022;36:103253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639388</ArticleId><ArticleId IdType="pubmed">36451358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang CY, Wang SI, Wei JC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366236</ArticleId><ArticleId IdType="pubmed">35971425</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D, Aenlle KK, Cohen J, et al. COVID-19 and Long COVID: disruption of the neurovascular unit, blood-brain barrier, and tight junctions. Neuroscientist. 2023;10738584231194927.</Citation><ArticleIdList><ArticleId IdType="pubmed">37694571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145(7):2555&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Sasaki N, Ohira Y. Low brain blood flow finding on SPECT in Long COVID patients with brain fog. QJM. 2023;116(10):877&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">37314982</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T, Wu J, Chen T, et al. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI Insight. 2022;7(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with Long COVID-associated cognitive impairment. Nat Neurosci. 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann A, Prosch H, Zehetmayer S, et al. Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS One. 2021;16(10):e0258351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553152</ArticleId><ArticleId IdType="pubmed">34710097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3(6):100663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Holms RD. Long COVID (PASC) is maintained by a self-sustaining pro-inflammatory TLR4/RAGE-loop of S100A8/A9 &gt; TLR4/RAGE signalling, inducing chronic expression of IL-1b, IL-6 and TNFa: anti-inflammatory ezrin peptides as potential therapy. Immuno. 2022;2(3):512&#x2013;33.</Citation></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224(11):1839&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra I, Molino A, et al. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study. Biomedicines. 2021;9(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretta P, Maniscalco M, Papa A, Lanzillo A, Trojano L, Ambrosino P. Cognitive impairment and endothelial dysfunction in convalescent COVID-19 patients undergoing rehabilitation. Eur J Clin Invest. 2022;52(2):e13726.</Citation><ArticleIdList><ArticleId IdType="pubmed">34921559</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8:1702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Andriuta D, Si-Ahmed C, Roussel M, et al. Clinical and imaging determinants of neurocognitive disorders in post-acute COVID-19 patients with cognitive complaints. J Alzheimers Dis. 2022;87(3):1239&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">35431242</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G, Agosta F, Canu E, et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol. 2022;269(7):3400&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersson I, Hansen BM, Svenningsson A, Lundstrom A. Cerebral microvascular injuries in severe COVID-19 infection: progression of white matter hyperintensities post-infection. BMJ Case Rep. 2022;15(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9472107</ArticleId><ArticleId IdType="pubmed">36100286</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman S, Green K, Lane TE. COVID-19 and the impact on Alzheimer&#x2019;s disease pathology. J Neurochem. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11024062</ArticleId><ArticleId IdType="pubmed">37850241</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Cao M, Xi Y, et al. Externalizing traits: shared causalities for COVID-19 and Alzheimer&#x2019;s dementia using Mendelian randomization analysis. PNAS Nexus. 2023;2(6):pgad198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10287533</ArticleId><ArticleId IdType="pubmed">37361546</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, Schulze A, Evers G, et al. Persistent capillary rarefication in Long COVID syndrome. Angiogenesis. 2023;26(1):53&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of Long COVID in elderly patients: an observational cohort study of over 2 million adults in the US. PLoS Med. 2023;20(4):e1004194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10150975</ArticleId><ArticleId IdType="pubmed">37068113</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of Long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9(10):815&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#x17a;dziewicz &#x141;, Tobis S, Chojnicki M, et al. Long-term impairment in activities of daily living following COVID-19 in residents of long-term care facilities. Med Sci Monit. 2023;29:e941197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10441154</ArticleId><ArticleId IdType="pubmed">37583130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N, Honda H, Nakano Y, et al. Hormonal trends in patients suffering from Long COVID symptoms. Endocr J. 2022;69(10):1173&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara MC, Zarcone C, Tassistro E, et al. Frailty and Long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? Aging Clin Exp Res. 2023;35(2):455&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9707219</ArticleId><ArticleId IdType="pubmed">36445566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bota AV, Bratosin F, Bandi SSS, et al. A comparative analysis of liver injury markers in post-COVID Syndrome among elderly patients: a prospective study. J Clin Med. 2024;13(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10889217</ArticleId><ArticleId IdType="pubmed">38398462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, Calvani R, Ciciarello F, et al. Malnutrition in COVID-19 survivors: prevalence and risk factors. Aging Clin Exp Res. 2023;35(10):2257&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10520154</ArticleId><ArticleId IdType="pubmed">37665556</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a M, Rodr&#xed;guez-Jim&#xe9;nez J, et al. Psychometric properties of the Functional Impairment Checklist (FIC) as a disease-specific Patient-Reported Outcome Measure (PROM) in previously hospitalized COVID-19 survivors with Long-COVID. Int J Environ Res Public Health. 2022;19(18).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9517100</ArticleId><ArticleId IdType="pubmed">36141732</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V, Pilotto A, Cotti Piccinelli S, et al. Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J Am Geriatr Soc. 2021;69(10):2778&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242714</ArticleId><ArticleId IdType="pubmed">34019707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan EYF, Zhang R, Mathur S, et al. Post-acute sequelae of COVID-19 in older persons: multi-organ complications and mortality. J Travel Med. 2023;30(5).</Citation><ArticleIdList><ArticleId IdType="pubmed">37310901</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt J, Carter B, Vilches-Moraga A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326416</ArticleId><ArticleId IdType="pubmed">32619408</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, Bradley E, Zeamer AL, et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and Long COVID. JCI Insight. 2021;6(20).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Aly M, Saber HG. Long COVID and chronic fatigue syndrome: a survey of elderly female survivors in Egypt. Int J Clin Pract. 2021;75(12):e14886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646426</ArticleId><ArticleId IdType="pubmed">34537995</ArticleId></ArticleIdList></Reference><Reference><Citation>Guaraldi G, Milic J, Barbieri S, et al. Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes. Sci Rep. 2023;13(1):8956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10235830</ArticleId><ArticleId IdType="pubmed">37268716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>